Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of rifampicin and ursodeoxycholic acid on biliary lipids and their transport and detoxification in patients with cholesterol gallstones
2005-005843-24Phase 4Active
- Sponsor
- Hanns-Ulrich Marschall
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rifampicin and ursodeoxycholic acid in cholelithiasis, sponsored by Hanns-Ulrich Marschall. Primary endpoints: Hepatic gene expression related to bile acid and bilirubin metabolism and detoxification, Hepatic protein expression related to bile acid and bilirubin metabolism and detoxification and 3 more. Started Dec 2005; status: active.
02
Drugs
rifampicinursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on 2005-005843-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005843-24.